The commentary, Unintended Consequences of Glucagon-like Peptide-1 Receptor Agonists Medication in Children and Adolescents A Call to Action, was published as a perspective in the Journal of Clinical and Translational Science
Use cases for GLP-1 research powered by Truveta Data The below examples highlight some of the key use cases for studying GLP-1 data, all of which have already been enabled by Truveta Data: Comparative effectiveness of GLP-1 therapies: In the largest comparative effectiveness study to date on tirzepatide vs
doi: 10.1007/s00125-021-05424-4 [DOI] [PubMed] [Google Scholar] 62.Yeh JA, Liu YC, Huang AH, et al
423 Furthermore, the study emphasized that neurons in specific brain regions, such as the hindbrain and hypothalamus, co-express GLP-1R along with 1-adrenergic and -opioid receptors, suggesting a localized mechanism within the CNS that could coordinate peripheral anti-inflammatory responses
Hypoglycaemia associated with Mounjaro, particularly when used in combination with other glucose-lowering agents, should be coded as E16.0 (Drug-induced hypoglycaemia without coma) or E16.1 (Other hypoglycaemia) as appropriate, with additional diabetes codes (E11
Muscle mass stabilizes blood sugar, boosts immunity, protects bones and joints, and revs up metabolism
